Publicaciones en colaboración con investigadores/as de University of Padua (3)

2021

  1. Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy

    Progress in Brain Research (Elsevier B.V.), pp. 1-73

2018

  1. Histamine H3 inverse agonist BF 2649 or antagonist with partial h4 agonist activity clobenpropit reduces amyloid beta peptide-induced brain pathology in alzheimer’s disease

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 312-321

2016

  1. Pathophysiology of blood-brain barrier in brain injury in cold and hot environments: Novel drug targets for neuroprotection

    CNS and Neurological Disorders - Drug Targets, Vol. 15, Núm. 9, pp. 1045-1071